Third intracellular loop of HCMV US28 is necessary for signaling and viral reactivation
Open Access
- 31 January 2025
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (1) , e0180124
Abstract
The human cytomegalovirus (HCMV) encoded chemokine receptor US28 plays a critical role in viral pathogenesis, mediating several processes such as cellular migration, differentiation, transformation, and viral latency and reactivation. Despite significant research examining the signal transduction pathways utilized by US28, the precise mechanism by which US28 activates these pathways remains unclear. We performed a mutational analysis of US28 to identify signaling domains that are critical for functional activities. Our results indicate that specific residues within the third intracellular loop (ICL3) of US28 are major determinants of G-protein coupling and downstream signaling activity. Alanine substitutions at positions S218, K223, and R225 attenuated US28-mediated activation of MAPK and RhoA signal transduction pathways. Furthermore, we show that mutations at positions S218, K223, or R225 result in impaired coupling to multiple Gα isoforms. However, these substitutions did not affect US28 plasma membrane localization or the receptor internalization rate. Utilizing CD34 + HPC models, we demonstrate that attenuation of US28 signaling via mutation of residues within the ICL3 region results in an inability of the virus to efficiently reactivate from latency. These results were recapitulated in vivo , utilizing a humanized mouse model of HCMV infection. Together, our results provide new insights into the mechanism by which US28 manipulates host signaling networks to mediate viral latency and reactivation. The results reported here will guide the development of targeted therapies to prevent HCMV-associated disease. IMPORTANCE: Human cytomegalovirus (HCMV) is a β-herpesvirus that infects between 44% and 100% of the world population. Primary infection is typically asymptomatic and results in the establishment of latent infection within CD34 + hematopoietic progenitor cells (HPCs). However, reactivation from latent infection remains a significant cause of morbidity and mortality in immunocompromised individuals. The viral chemokine receptor US28 influences various cellular processes crucial for viral latency and reactivation, yet the precise mechanism by which US28 functions remains unclear. Through mutational analysis, we identified key residues within the third intracellular loop (ICL3) of US28 that govern G-protein coupling, downstream signaling, and viral reactivation in vitro and in vivo . These findings offer novel insights into how US28 manipulates host signaling networks to regulate HCMV latency and reactivation and expand our understanding of HCMV pathogenesis.Keywords
Funding Information
- HHS | National Institutes of Health (AI170496-01A1)
- HHS | National Institutes of Health (AI127335)
- HHS | National Institutes of Health (AI21640)
This publication has 96 references indexed in Scilit:
- Human Embryonic Stem Cells as a Model for Hematopoietic Stem Cell Differentiation and Viral InfectionCurrent Protocols, 2022
- The complex biology of human cytomegalovirus latency2022
- Human Cytomegaloviruses2021
- Barbadin selectively modulates FPR2-mediated neutrophil functions independent of receptor endocytosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2020
- Illuminating G-Protein-Coupling Selectivity of GPCRsCell, 2019
- Emerging roles of cytomegalovirus-encoded G protein-coupled receptors during lytic and latent infectionMedical Microbiology and Immunology, 2019
- Cytomegalovirus latency and reactivation: recent insights into an age old problemReviews in Medical Virology, 2015
- Hematopoietic Long-Term Culture (hLTC) for Human Cytomegalovirus Latency and Reactivation2014
- The third intracellular loop plays a critical role in bitter taste receptor activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2014
- YM-254890 analogues, novel cyclic depsipeptides with Gαq/11 inhibitory activity from Chromobacterium sp. QS3666Bioorganic & Medicinal Chemistry, 2004